Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Invictus MD Strategies Corp IVITF

Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.


GREY:IVITF - Post by User

Post by chris579457on Aug 01, 2020 12:46pm
665 Views
Post# 31353870

sale has been confirmed

sale has been confirmed
16 hours ago by CNW Group
Companies Mentioned: IVITF

Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced that it has received both creditor and Court approval of the investment agreement for the sale of its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage"), to Acreage Developments Corp. (the "Investor"), a privately-owned company that is unrelated to the Company and its directors and officers.

 

Invictus MD Strategies Corp. (NEX: GENE.H) (the "Company") announced that it has received both creditor and Court approval of the investment agreement for the sale of its wholly-owned subsidiary, Acreage Pharms Ltd. ("Acreage"), to Acreage Developments Corp. (the "Investor"), a privately-owned company that is unrelated to the Company and its directors and officers.

At a creditors' meeting held July 21, 2020, the creditors unanimously approved the transaction with the Investor and a plan of compromise and arrangement (the "Plan"). The Court subsequently approved the transaction and the Plan, as part of the CCAA proceedings currently underway involving the Company and its subsidiaries. As part of the transaction and Plan, all existing shares of Acreage will be cancelled and new shares issued to the Investor. As a consequence, the Investor will be the sole shareholder of Acreage, and it is not anticipated that the sale will result in any recovery for creditors or the common shareholders of the Company. Recoveries will be limited to the creditors of Acreage.

The Company continues to seek buyers for its remaining assets. There can be no assurance that any transaction involving the remaining assets of the Company will eventuate.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


<< Previous
Bullboard Posts
Next >>